144 related articles for article (PubMed ID: 37981495)
1. Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds.
Kawada T; Shim SR; Quhal F; Rajwa P; Pradere B; Yanagisawa T; Bekku K; Laukhtina E; von Deimling M; Teoh JY; Karakiewicz PI; Araki M; Shariat SF
Eur Urol Oncol; 2023 Nov; ():. PubMed ID: 37981495
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Kawada T; Yanagisawa T; Rajwa P; Sari Motlagh R; Mostafaei H; Quhal F; Laukhtina E; Aydh A; König F; Pallauf M; Pradere B; Ceci F; Baltzer PAT; Hacker M; Rasul S; Karakiewicz PI; Araki M; Nasu Y; Shariat SF
Eur Urol Oncol; 2022 Aug; 5(4):390-400. PubMed ID: 35715320
[TBL] [Abstract][Full Text] [Related]
3. Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis.
Agnello L; Vidali M; Giglio RV; Gambino CM; Ciaccio AM; Lo Sasso B; Ciaccio M
Clin Chem Lab Med; 2022 Jul; 60(8):1261-1277. PubMed ID: 35567430
[TBL] [Abstract][Full Text] [Related]
4. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions.
Hendriks RJ; van Oort IM; Schalken JA
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627
[TBL] [Abstract][Full Text] [Related]
5. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Del Pino-Sedeño T; Infante-Ventura D; de Armas Castellano A; de Pablos-Rodríguez P; Rueda-Domínguez A; Serrano-Aguilar P; Trujillo-Martín MM
Eur Urol Open Sci; 2022 Dec; 46():105-127. PubMed ID: 36388432
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review and Meta-analysis of the Diagnostic Accuracy of Prostate Health Index and 4-Kallikrein Panel Score in Predicting Overall and High-grade Prostate Cancer.
Russo GI; Regis F; Castelli T; Favilla V; Privitera S; Giardina R; Cimino S; Morgia G
Clin Genitourin Cancer; 2017 Aug; 15(4):429-439.e1. PubMed ID: 28111174
[TBL] [Abstract][Full Text] [Related]
7. A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer.
Wagaskar VG; Sobotka S; Ratnani P; Young J; Lantz A; Parekh S; Falagario UG; Li L; Lewis S; Haines K; Punnen S; Wiklund P; Tewari A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1357. PubMed ID: 33661541
[TBL] [Abstract][Full Text] [Related]
8. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Mazzone E; Stabile A; Pellegrino F; Basile G; Cignoli D; Cirulli GO; Sorce G; Barletta F; Scuderi S; Bravi CA; Cucchiara V; Fossati N; Gandaglia G; Montorsi F; Briganti A
Eur Urol Oncol; 2021 Oct; 4(5):697-713. PubMed ID: 33358543
[TBL] [Abstract][Full Text] [Related]
9. Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study.
Wu B; Shao Y; Lin X; Hasi C; Jia W; Wang D; Cao X
Transl Androl Urol; 2023 Mar; 12(3):425-432. PubMed ID: 37032752
[TBL] [Abstract][Full Text] [Related]
10. Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection.
Chiu ST; Cheng YT; Pu YS; Lu YC; Hong JH; Chung SD; Chiang CH; Huang CY
Front Oncol; 2021; 11():772182. PubMed ID: 34869007
[TBL] [Abstract][Full Text] [Related]
11. Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection.
Chen H; Qian Y; Wu Y; Shi B; Zhou J; Qu F; Gu Z; Ding J; Yu Y
Front Oncol; 2022; 12():864111. PubMed ID: 35463344
[TBL] [Abstract][Full Text] [Related]
12. Concordance and Performance of 4Kscore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.
Wysock JS; Becher E; Persily J; Loeb S; Lepor H
Urology; 2020 Jul; 141():119-124. PubMed ID: 32294481
[TBL] [Abstract][Full Text] [Related]
13. MRI Fusion-Targeted Transrectal Prostate Biopsy and the Role of Prostate-Specific Antigen Density and Prostate Health Index for the Detection of Clinically Significant Prostate Cancer in Southeast Asian Men.
Tan TW; Png KS; Lee CH; Yuwono A; Yeow Y; Chong KT; Lee YM; Tan CH; Tan YK
J Endourol; 2017 Nov; 31(11):1111-1116. PubMed ID: 28797178
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer.
Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Song W
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509551
[TBL] [Abstract][Full Text] [Related]
15. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
Vedder MM; de Bekker-Grob EW; Lilja HG; Vickers AJ; van Leenders GJ; Steyerberg EW; Roobol MJ
Eur Urol; 2014 Dec; 66(6):1109-15. PubMed ID: 25168616
[TBL] [Abstract][Full Text] [Related]
16. Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification.
Ferro M; Rocco B; Maggi M; Lucarelli G; Falagario UG; Del Giudice F; Crocetto F; Barone B; La Civita E; Lasorsa F; Brescia A; Catellani M; Busetto GM; Tataru OS; Terracciano D
Expert Rev Mol Diagn; 2023; 23(12):1061-1070. PubMed ID: 37897252
[TBL] [Abstract][Full Text] [Related]
17. Micro-ultrasound-guided biopsies versus systematic biopsies in the detection of prostate cancer: a systematic review and meta-analysis.
Dariane C; Ploussard G; Barret E; Beauval JB; Brureau L; Créhange G; Fromont G; Gauthé M; Mathieu R; Renard-Penna R; Roubaud G; Ruffion A; Sargos P; Rouprêt M; Fiard G;
World J Urol; 2023 Mar; 41(3):641-651. PubMed ID: 35835886
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of the prostate health index density and multiparametric magnetic resonance imaging in diagnosing clinically significant prostate cancer.
Chen Y; Xu D; Ruan M; Li H; Lin G; Song G
Investig Clin Urol; 2023 Jul; 64(4):363-372. PubMed ID: 37417561
[TBL] [Abstract][Full Text] [Related]
19. Urine-derived exosomal PSMA is a promising diagnostic biomarker for the detection of prostate cancer on initial biopsy.
Wang CB; Chen SH; Zhao L; Jin X; Chen X; Ji J; Mo ZN; Wang FB
Clin Transl Oncol; 2023 Mar; 25(3):758-767. PubMed ID: 36266386
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.
Stabile A; Dell'Oglio P; Soligo M; De Cobelli F; Gandaglia G; Fossati N; Esposito A; Brembilla G; Karnes RJ; Montorsi F; Briganti A
Eur Urol Oncol; 2021 Aug; 4(4):594-600. PubMed ID: 31204312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]